These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 24780826)

  • 1. Prognostic value of myogenic differentiation in undifferentiated pleomorphic sarcomas of soft tissue.
    Cipriani NA; Kurzawa P; Ahmad RA; Deshpande V; Hornicek FJ; Mullen JT; Nielsen GP
    Hum Pathol; 2014 Jul; 45(7):1504-8. PubMed ID: 24780826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathological re-classification of extremity pleomorphic soft tissue sarcoma has clinical relevance.
    Massi D; Beltrami G; Capanna R; Franchi A
    Eur J Surg Oncol; 2004 Dec; 30(10):1131-6. PubMed ID: 15522563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The comparative role of immunohistochemistry and electron microscopy in the identification of myogenic differentiation in soft tissue pleomorphic sarcomas.
    Franchi A; Massi D; Santucci M
    Ultrastruct Pathol; 2005; 29(3-4):295-304. PubMed ID: 16036884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myoid differentiation and prognosis in adult pleomorphic sarcomas of the extremity: an analysis of 92 cases.
    Deyrup AT; Haydon RC; Huo D; Ishikawa A; Peabody TD; He TC; Montag AG
    Cancer; 2003 Aug; 98(4):805-13. PubMed ID: 12910526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Clinical and Molecular Factors Impacting Oncologic Outcomes in Undifferentiated Pleomorphic Sarcoma.
    Roland CL; May CD; Watson KL; Al Sannaa GA; Dineen SP; Feig R; Landers S; Ingram DR; Wang WL; Guadagnolo BA; Feig B; Hunt KK; Cormier JN; Lazar AJ; Torres KE
    Ann Surg Oncol; 2016 Jul; 23(7):2220-8. PubMed ID: 26847678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MFH revisited: outcome after surgical treatment of undifferentiated pleomorphic or not otherwise specified (NOS) sarcomas of the extremities -- an analysis of 140 patients.
    Lehnhardt M; Daigeler A; Homann HH; Schwaiberger V; Goertz O; Kuhnen C; Steinau HU
    Langenbecks Arch Surg; 2009 Mar; 394(2):313-20. PubMed ID: 18584203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting the prognosis of undifferentiated pleomorphic soft tissue sarcoma: a 20-year experience of 266 cases.
    Vodanovich DA; Spelman T; May D; Slavin J; Choong PFM
    ANZ J Surg; 2019 Sep; 89(9):1045-1050. PubMed ID: 31364245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of p16(INK4a) is associated with reduced patient survival in soft tissue tumours, and indicates a senescence barrier.
    Knösel T; Altendorf-Hofmann A; Lindner L; Issels R; Hermeking H; Schuebbe G; Gibis S; Siemens H; Kampmann E; Kirchner T
    J Clin Pathol; 2014 Jul; 67(7):592-8. PubMed ID: 24747207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sampling modality influences the predictive value of grading in adult soft tissue extremity sarcomas.
    Khoja H; Griffin A; Dickson B; Wunder J; Ferguson P; Howarth D; Kandel R
    Arch Pathol Lab Med; 2013 Dec; 137(12):1774-9. PubMed ID: 24283858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-inducible factor 1α predicts recurrence in high-grade soft tissue sarcoma of extremities and trunk wall.
    Nyström H; Jönsson M; Werner-Hartman L; Nilbert M; Carneiro A
    J Clin Pathol; 2017 Oct; 70(10):879-885. PubMed ID: 28404817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of necrosis after neoadjuvant therapy for soft tissue sarcoma.
    Vaynrub M; Taheri N; Ahlmann ER; Yao C; Fedenko AN; Allison DC; Chawla SP; Menendez LR
    J Surg Oncol; 2015 Feb; 111(2):152-7. PubMed ID: 25175933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the Role of Neoadjuvant Chemotherapy in Primary High-Risk Truncal/Extremity Soft Tissue Sarcomas: An Analysis of the Multi-institutional U.S. Sarcoma Collaborative.
    Zaidi MY; Ethun CG; Tran TB; Poultsides G; Grignol VP; Howard JH; Bedi M; Mogal H; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Krasnick B; Fields RC; Oskouei S; Reimer N; Monson D; Maithel SK; Cardona K
    Ann Surg Oncol; 2019 Oct; 26(11):3542-3549. PubMed ID: 31342400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soft tissue sarcomas of the chest wall. Results of surgical resection.
    Gordon MS; Hajdu SI; Bains MS; Burt ME
    J Thorac Cardiovasc Surg; 1991 May; 101(5):843-54. PubMed ID: 2023441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of undifferentiated pleomorphic sarcoma: Experience from the US Sarcoma Collaborative.
    Makris EA; Tran TB; Delitto DJ; Lee B; Ethun CG; Grignol V; Harrison Howard J; Bedi M; Clark Gamblin T; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Cullinan D; Fields RC; Cardona K; Poultsides G; Kirane A
    J Surg Oncol; 2024 Jun; 129(7):1354-1363. PubMed ID: 38562002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified staging system for extremity soft tissue sarcomas.
    Ramanathan RC; A'Hern R; Fisher C; Thomas JM
    Ann Surg Oncol; 1999; 6(1):57-69. PubMed ID: 10030416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histological grading and MIB-1 labeling index of soft-tissue sarcomas.
    Hasegawa T
    Pathol Int; 2007 Mar; 57(3):121-5. PubMed ID: 17295643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of proliferation in pleomorphic soft tissue sarcomas: a new look at an old measure.
    Seinen JM; Jönsson M; Bendahl PO; Baldetorp B; Rambech E; Åkerman M; Rydholm A; Nilbert M; Carneiro A
    Hum Pathol; 2012 Dec; 43(12):2247-54. PubMed ID: 22789784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soft tissue sarcoma of extremities: the prognostic significance of adequate surgical margins in primary operation and reoperation after recurrence.
    Liu CY; Yen CC; Chen WM; Chen TH; Chen PC; Wu HT; Shiau CY; Wu YC; Liu CL; Tzeng CH
    Ann Surg Oncol; 2010 Aug; 17(8):2102-11. PubMed ID: 20217247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Management of soft tissue sarcomas in first isolated local recurrence: a retrospective study of 83 cases].
    Moureau-Zabotto L; Thomas L; Bui BN; Chevreau C; Stockle E; Martel P; Bonneviale P; Marques B; Coindre JM; Kantor G; Matsuda T; Delannes M
    Cancer Radiother; 2004 Oct; 8(5):279-87. PubMed ID: 15561593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis has no prognostic value in neoadjuvant chemotherapy for soft tissue sarcoma.
    Menendez LR; Ahlmann ER; Savage K; Cluck M; Fedenko AN
    Clin Orthop Relat Res; 2007 Feb; 455():219-24. PubMed ID: 17016226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.